Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Spectral Cancer Tissue Recognition - I

View source ↗

Summary

A clinical trial update indicates that Spectral Cancer Tissue Recognition - I is currently recruiting to evaluate margin assessment in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SPCTR | Conditions: Margin Assessment, Breast Cancer | Status: RECRUITING